MobiHealth News June 5, 2025
Alexandre Momeni, a partner at General Catalyst, describes how the VC firm funds visionary founders building frontier technologies while balancing high-risk bets with responsible innovation and strategic portfolio construction.
U.S.-based General Catalyst is one of the largest venture capital firms globally, with a diverse portfolio of companies across various industries, including healthcare.
Alexandre Momeni, a partner at General Catalyst focusing on AI infrastructure and health/bio, sat down with MobiHealthNews to discuss the investor’s perspective on funding emerging technologies, the risks associated with these investments and the potential for the technology to change society as a whole.
MobiHealthNews: What do you consider when investing in emerging technologies?
Alexandre Momeni: I think first and foremost, at General Catalyst, when we invest at...
Today's Sponsors
Today's Sponsor